A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial in patients ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...
Dr. Bright is a virologist and a former head of the Biomedical Advanced Research and Development Authority. In early 2020, when the first genetic sequence of the new coronavirus was posted online, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results